Actionable insights straight to your inbox

Equities logo

Ruthigen, Inc. Files SEC Form 10-K, Annual Report [Section 13 And 15(D), Not S-K Item 405] (Jun. 30, 2014)

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission

By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Ruthigen, Inc. (Form 10-K) was posted on June 30, 2014.
The SIC code for this company is 2834, Pharmaceutical Preparations.
There were 11 documents filed with this form. The SEC file number is 0001144204-14-040451.
The contact information for this company is 2455 BENNETT VALLEY RD. SUITE C116, SANTA ROSA CA 95404, (707) 525-9900.
Our editors provided additional information about Form 10-K: This is the annual report that most reporting companies file with the Commission. It provides a comprehensive overview of the registrant’s business. The report must be filed within 90 days after the end of the company’s fiscal year.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1574235/0001144204-14-040451-index.html.
Keywords for this news article include: Pharmaceutical Preparations, SEC Filing, Ruthigen Inc..
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

If you don't feel that U.S. culture (and much of the world in different ways) is in turmoil, you are not paying attention.
Equities short logo
Equities short logo